1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Hormone Receptor Positive: new trials by email Literature Review of Hormone Receptor Positive trials Research Report on Hormone Receptor Positive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer Patritumab deruxtecan, Trastuzumab deruxtecan - Hormone Receptor Positive, HER2-low or HER2-ultralow | Phase 1 / Phase 2 | Recruiting | Daiichi Sankyo | 220 | 2026-09-17 | 2026-10-01 |
| Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib Neratinib, Loperamide, Colesevelam - Early-stage Breast Cancer, HER2 Positive Breast Cancer | Phase 2 | Active not recruiting | Spanish Breast Cancer Research Group | 177 | 2022-08-31 | 2025-04-01 |
| A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer Palbociclib, Tamoxifen, Fulvestrant - Metastatic Breast Cancer, Hormone Receptor Positive | Phase 2 | Completed | University of California, San Francisco | 70 | 2015-10-19 | 2022-03-16 |
Breast Neoplasms (3)
Breast Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3)
Colesevelam Hydrochloride (1) · Fulvestrant (1) · Loperamide (1) · Tamoxifen (1) · neratinib (1) · palbociclib (1) · patritumab deruxtecan (1) · trastuzumab deruxtecan (1)
Daiichi Sankyo (1) · Spanish Breast Cancer Research Group (1) · University of California, San Francisco (1)
Spain (2) · United States (2) · Belgium (1) · France (1) · Italy (1) · Japan (1) · South Korea (1) · Taiwan (1)
Hope S Rugo, MD (1)
2019 (1)